Company: JUNS
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001493152-25-018523
Chunk: 73

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 73
---
12) | Includes                                                                                    
 514,609 shares of common stock that may be acquired within 60 days of October 14, 2025 upon 
 exercise of vested options.                                                                 |
| (13) | Includes                                                                                    
 326,319 shares of common stock that may be acquired within 60 days of October 14, 2025 upon 
 exercise of vested options.                                                                 |

| -45- |

Securities Authorized for Issuance under Equity Compensation Plans

The following table provides information as of December 31, 2024, regarding our compensation plans under which equity securities are authorized for issuance:

| Plan                               
 category                           |     | Number                                                                               
 of securities to be issued upon exercise of outstanding options, warrants and rights |            |     | Weighted-average                                               
 exercise price of outstanding options, warrants and rights ($) |      |     | Number                                                                                                                               
 of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |           |
|                                    |     | -a                                                                                   |            |     | -b                                                             |      |     | -c                                                                                                                                   |           |
| Equity compensation                
 plans approved by security holders |     |                                                                                      |  8,311,224 |     |                                                                | 0.94 |     |                                                                                                                                      | 5,849,061 |
| Equity compensation plans          
 not approved by security holders   |     |                                                                                      |  5,308,303 |     |                                                                | 1.20 |     |                                                                                                                                      |         0 |
| Total                              |     |                                                                                      | 13,619,527 |     |                                                                | 1.04 |     |                                                                                                                                      | 5,849,061 |

The Company’s stockholders approved the 2016 Equity Incentive Plan (“ 2016 Plan”) on January 4, 2016. Under the 2016 Plan, as modified, 8,437,500 shares of common stock are authorized for issuance to employees, officers, directors, consultants. The 2016 Plan authorizes the grant of nonqualified stock options and incentive stock options, restricted stock awards, restricted stock units, stock appreciation rights, under the 2016 Plan. The Company does not intend to make any additional grants under the 2016 Plan.

The Board and stockholders of the Company approved the 2021 Equity Incentive Plan (the “ 2021 Plan”) on September 17, 2021. Under the 202